CapCell Biologics Overview

  • Founded
  • 2017
  • Status
  • Out of Business
  • Employees
  • 3
  • Latest Deal Type
  • Out of Business

CapCell Biologics General Information


Developer of advanced drug delivery therapy designed to be used for enzyme replacement using carbon nanotube capsules. The company's therapy allows the implantation of biological particles in the patient's body through outpatient procedures, enabling doctors to serve patients with diabetes, cancer, and other rare diseases more effectively.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 1020 Park Plaza
  • Suite 3B
  • Brooklyn, NY 11213
  • United States
+1 (215) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CapCell Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 19-May-2022 0000 Completed Out of Business
4. Early Stage VC 31-Mar-2020 00000 Cancelled Generating Revenue
3. Grant 08-Apr-2019 0000 0000 Completed Generating Revenue
2. Seed Round 29-Jan-2019 $40K $40K Completed Generating Revenue
1. Accelerator/Incubator 08-Jan-2019 Completed Generating Revenue
To view CapCell Biologics’s complete valuation and funding history, request access »

CapCell Biologics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial